Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
enVVeno Medical (NVNO)
NASDAQ:NVNO
Holding NVNO?
Track your performance easily
NVNO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.76 - $6.97
Previous Close$2.85
Volume244.14K
Average Volume (3M)157.52K
Market Cap
$49.98M
Enterprise Value$2.75M
Total Cash (Recent Filing)$48.38M
Total Debt (Recent Filing)$1.15M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Feb 27, 2025EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.39
Shares Outstanding17,536,000
10 Day Avg. Volume112,782
30 Day Avg. Volume157,518
Standard Deviation0.22
R-Squared0.08
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.06
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
enVVeno Medical News
Ownership Overview
― Insiders
4.14% Mutual Funds
23.21% Other Institutional Investors
69.21% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
NVNO FAQ
What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $2.76 and its highest was $6.97 in the past 12 months.
What is enVVeno Medical’s market cap?
Currently, no data Available
When is enVVeno Medical’s upcoming earnings report date?
enVVeno Medical’s upcoming earnings report date is Feb 27, 2025 which is in 66 days.
How were enVVeno Medical’s earnings last quarter?
enVVeno Medical released its earnings results on Oct 31, 2024. The company reported -$0.351 earnings per share for the quarter, missing the consensus estimate of -$0.33 by -$0.021.
Is enVVeno Medical overvalued?
According to Wall Street analysts enVVeno Medical’s price is currently Overvalued.
Does enVVeno Medical pay dividends?
enVVeno Medical does not currently pay dividends.
What is enVVeno Medical’s EPS estimate?
enVVeno Medical’s EPS estimate is -$0.35.
How many shares outstanding does enVVeno Medical have?
enVVeno Medical has 17,536,000 shares outstanding.
What happened to enVVeno Medical’s price movement after its last earnings report?
enVVeno Medical reported an EPS of -$0.351 in its last earnings report, missing expectations of -$0.33. Following the earnings report the stock price went up 1.813%.
Which hedge fund is a major shareholder of enVVeno Medical?
Among the largest hedge funds holding enVVeno Medical’s share is Perceptive Advisors LLC. It holds enVVeno Medical’s shares valued at 2M.
---
enVVeno Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NVNO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 71.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.58%
12-Months-Change
Fundamentals
Return on Equity
-58.76%
Trailing 12-Months
Asset Growth
79.36%
Trailing 12-Months
Company Description
enVVeno Medical
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
---
Technical Analysis
---